Long-Term Effectiveness and Safety of Bimekizumab in Patients with Moderate to Severe Hidradenitis Suppurativa Under Real Clinical Practice Conditions: The Importance of Combined Treatment in Hurley III Patients and Potential Factors Associated with Complete Response.

Mansilla-Polo M, García-Moronta C, Fernández-Crehuet P, Garbayo-Salmons P, Pons-Benavent M, Aguilar-González L, Jiménez-Gallo D, Alcalá-García R, Martín-Ezquerra G, Martorell A, Mahiques-Santos L, Alfageme-Roldán F, Escutia-Muñoz B, Sahuquillo-Torralba A, Fayos-Gregori R, Soto-Moreno A, Sánchez-Gutiérrez I, Botella-Estrada R, Vilarrasa E, Molina-Leyva A, Spanish Hidradenitis Suppurativa Group (GEHS)

Open source

DOI: 10.1007/s13555-025-01521-z
Published: 2025 Nov
Container: Dermatology and therapy
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1007/s13555-025-01521-z,
  title = {Long-Term Effectiveness and Safety of Bimekizumab in Patients with Moderate to Severe Hidradenitis Suppurativa Under Real Clinical Practice Conditions: The Importance of Combined Treatment in Hurley III Patients and Potential Factors Associated with Complete Response.},
  author = {Mansilla-Polo M and García-Moronta C and Fernández-Crehuet P and Garbayo-Salmons P and Pons-Benavent M and Aguilar-González L and Jiménez-Gallo D and Alcalá-García R and Martín-Ezquerra G and Martorell A and Mahiques-Santos L and Alfageme-Roldán F and Escutia-Muñoz B and Sahuquillo-Torralba A and Fayos-Gregori R and Soto-Moreno A and Sánchez-Gutiérrez I and Botella-Estrada R and Vilarrasa E and Molina-Leyva A and Spanish Hidradenitis Suppurativa Group (GEHS)},
  year = {2025},
  journal = {Dermatology and therapy},
  doi = {10.1007/s13555-025-01521-z},
  url = {https://doi.org/10.1007/s13555-025-01521-z}
}

RIS

TY  - JOUR
TI  - Long-Term Effectiveness and Safety of Bimekizumab in Patients with Moderate to Severe Hidradenitis Suppurativa Under Real Clinical Practice Conditions: The Importance of Combined Treatment in Hurley III Patients and Potential Factors Associated with Complete Response.
AU  - Mansilla-Polo M
AU  - García-Moronta C
AU  - Fernández-Crehuet P
AU  - Garbayo-Salmons P
AU  - Pons-Benavent M
AU  - Aguilar-González L
AU  - Jiménez-Gallo D
AU  - Alcalá-García R
AU  - Martín-Ezquerra G
AU  - Martorell A
AU  - Mahiques-Santos L
AU  - Alfageme-Roldán F
AU  - Escutia-Muñoz B
AU  - Sahuquillo-Torralba A
AU  - Fayos-Gregori R
AU  - Soto-Moreno A
AU  - Sánchez-Gutiérrez I
AU  - Botella-Estrada R
AU  - Vilarrasa E
AU  - Molina-Leyva A
AU  - Spanish Hidradenitis Suppurativa Group (GEHS)
PY  - 2025
JO  - Dermatology and therapy
DO  - 10.1007/s13555-025-01521-z
UR  - https://doi.org/10.1007/s13555-025-01521-z
ER  -

APA

M, M., C, G., P, F., P, G., M, P., L, A., D, J., R, A., G, M., A, M., L, M., F, A., B, E., A, S., R, F., A, S., I, S., R, B., E, V., A, M., & (GEHS), S. H. S. G. (2025). Long-Term Effectiveness and Safety of Bimekizumab in Patients with Moderate to Severe Hidradenitis Suppurativa Under Real Clinical Practice Conditions: The Importance of Combined Treatment in Hurley III Patients and Potential Factors Associated with Complete Response.. Dermatology and therapy. https://doi.org/10.1007/s13555-025-01521-z

Source records

pubmed · retrieved 2026-09-26T18:23:22.020Z